Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.

Jacob J, Bellach J, Grützmann R, Alldinger I, Pilarsky C, Dietel M, Kristiansen G.

Pancreatology. 2004;4(5):454-60. Epub 2004 Jul 14.

PMID:
15256807
2.

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M.

Clin Cancer Res. 2003 Oct 15;9(13):4906-13.

3.

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I.

Br J Cancer. 2003 Jan 27;88(2):231-6.

4.

Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.

Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M.

Hum Pathol. 2010 Oct;41(10):1466-74. doi: 10.1016/j.humpath.2010.04.004.

PMID:
20619441
5.

Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.

Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, Kristiansen G.

Clin Cancer Res. 2005 Sep 15;11(18):6574-81.

6.

The role of CD24 in various human epithelial neoplasias.

Lim SC, Oh SH.

Pathol Res Pract. 2005;201(7):479-86.

PMID:
16164042
7.

Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.

Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G.

Gynecol Oncol. 2005 May;97(2):379-86.

PMID:
15863133
8.
9.

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S.

Am J Pathol. 2002 Oct;161(4):1215-21.

10.

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas.

Immervoll H, Hoem D, Sakariassen PØ, Steffensen OJ, Molven A.

BMC Cancer. 2008 Feb 8;8:48. doi: 10.1186/1471-2407-8-48.

11.

CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.

Kristiansen G, Pilarsky C, Pervan J, Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M.

Prostate. 2004 Feb 1;58(2):183-92.

PMID:
14716744
12.

Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.

Zhu J, Nie S, Wu J, Lubman DM.

J Proteome Res. 2013 Jun 7;12(6):2791-804. doi: 10.1021/pr400139c. Epub 2013 May 29.

13.

Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.

Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH.

Ann Surg Oncol. 2007 Oct;14(10):2748-58. Epub 2007 Aug 7.

PMID:
17680316
14.

Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.

Hassan R, Laszik ZG, Lerner M, Raffeld M, Postier R, Brackett D.

Am J Clin Pathol. 2005 Dec;124(6):838-45.

15.

Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients.

Surowiak P, Materna V, Kłak K, Spaczyński M, Dietel M, Kristiansen G, Lage H, Zabel M.

Pol J Pathol. 2005;56(2):69-74.

PMID:
16092668
16.

CD24 expression is a poor prognostic marker in endometrial carcinoma.

Karahan N, Güney M, Oral B, Kapucuoglu N, Mungan T.

Eur J Gynaecol Oncol. 2006;27(5):500-4.

PMID:
17139987
17.

Bcl-2 expression in pancreas development and pancreatic cancer progression.

Campani D, Esposito I, Boggi U, Cecchetti D, Menicagli M, De Negri F, Colizzi L, Del Chiaro M, Mosca F, Fornaciari G, Bevilacqua G.

J Pathol. 2001 Aug;194(4):444-50.

PMID:
11523052
18.

Tumour biological aspects of CD24, a mucin-like adhesion molecule.

Kristiansen G, Sammar M, Altevogt P.

J Mol Histol. 2004 Mar;35(3):255-62. Review.

PMID:
15339045
19.

Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.

Zhu J, He J, Liu Y, Simeone DM, Lubman DM.

J Proteome Res. 2012 Apr 6;11(4):2272-81. doi: 10.1021/pr201059g. Epub 2012 Feb 28.

20.

Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma.

Künzli BM, Berberat PO, Zhu ZW, Martignoni M, Kleeff J, Tempia-Caliera AA, Fukuda M, Zimmermann A, Friess H, Büchler MW.

Cancer. 2002 Jan 1;94(1):228-39.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk